1	chemical	_	CHEMICAL	_	NN	0	_	_	_	_	_	chemical.n	Substance	O
2	reviews	_	UNK	_	NNP	0	_	_	_	_	_	_	_	S-Type

1	targeted	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
2	delivery	_	delivery	_	NN	2	_	_	_	_	_	delivery.n	Delivery	O
3	combined	_	combine	_	VBN	2	_	_	_	_	_	_	_	B-Purpose
4	with	_	with	_	IN	2	_	_	_	_	_	_	_	I-Purpose
5	controlled	_	controlled	_	JJ	2	_	_	_	_	_	_	_	I-Purpose
6	drug	_	drug	_	NN	2	_	_	_	_	_	_	_	I-Purpose
7	release	_	release	_	NN	2	_	_	_	_	_	_	_	I-Purpose
8	has	_	have	_	VBZ	2	_	_	_	_	_	_	_	I-Purpose
9	a	_	a	_	DT	2	_	_	_	_	_	_	_	I-Purpose
10	pivotal	_	UNK	_	JJ	2	_	_	_	_	_	_	_	I-Purpose
11	role	_	role	_	NN	2	_	_	_	_	_	_	_	I-Purpose
12	in	_	in	_	IN	2	_	_	_	_	_	_	_	I-Purpose
13	the	_	the	_	DT	2	_	_	_	_	_	_	_	I-Purpose
14	future	_	future	_	NN	2	_	_	_	_	_	_	_	I-Purpose
15	of	_	of	_	IN	2	_	_	_	_	_	_	_	I-Purpose
16	personalized	_	UNK	_	JJ	2	_	_	_	_	_	_	_	I-Purpose
17	medicine	_	medicine	_	NN	2	_	_	_	_	_	_	_	I-Purpose
18	.	_	.	_	.	2	_	_	_	_	_	_	_	I-Purpose

1	targeted	_	UNK	_	VBN	2	_	_	_	_	_	_	_	B-Degree
2	delivery	_	delivery	_	NN	2	_	_	_	_	_	_	_	I-Degree
3	combined	_	combine	_	VBN	2	_	_	_	_	_	_	_	I-Degree
4	with	_	with	_	IN	2	_	_	_	_	_	_	_	I-Degree
5	controlled	_	controlled	_	JJ	2	_	_	_	_	_	_	_	S-Re-encoding
6	drug	_	drug	_	NN	2	_	_	_	_	_	drug.n	Cause_harm	S-Degree
7	release	_	release	_	NN	2	_	_	_	_	_	_	_	B-Manner
8	has	_	have	_	VBZ	2	_	_	_	_	_	_	_	I-Manner
9	a	_	a	_	DT	2	_	_	_	_	_	_	_	I-Manner
10	pivotal	_	UNK	_	JJ	2	_	_	_	_	_	_	_	I-Manner
11	role	_	role	_	NN	2	_	_	_	_	_	_	_	I-Manner
12	in	_	in	_	IN	2	_	_	_	_	_	_	_	I-Manner
13	the	_	the	_	DT	2	_	_	_	_	_	_	_	I-Manner
14	future	_	future	_	NN	2	_	_	_	_	_	_	_	I-Manner
15	of	_	of	_	IN	2	_	_	_	_	_	_	_	I-Manner
16	personalized	_	UNK	_	JJ	2	_	_	_	_	_	_	_	I-Manner
17	medicine	_	medicine	_	NN	2	_	_	_	_	_	_	_	I-Manner
18	.	_	.	_	.	2	_	_	_	_	_	_	_	I-Manner

1	targeted	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
2	delivery	_	delivery	_	NN	2	_	_	_	_	_	_	_	O
3	combined	_	combine	_	VBN	2	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	2	_	_	_	_	_	_	_	O
5	controlled	_	controlled	_	JJ	2	_	_	_	_	_	_	_	O
6	drug	_	drug	_	NN	2	_	_	_	_	_	_	_	O
7	release	_	release	_	NN	2	_	_	_	_	_	_	_	O
8	has	_	have	_	VBZ	2	_	_	_	_	_	have.v	Possession	O
9	a	_	a	_	DT	2	_	_	_	_	_	_	_	O
10	pivotal	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
11	role	_	role	_	NN	2	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
14	future	_	future	_	NN	2	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
16	personalized	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
17	medicine	_	medicine	_	NN	2	_	_	_	_	_	_	_	O
18	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	targeted	_	UNK	_	VBN	2	_	_	_	_	_	_	_	B-Performance
2	delivery	_	delivery	_	NN	2	_	_	_	_	_	_	_	I-Performance
3	combined	_	combine	_	VBN	2	_	_	_	_	_	_	_	I-Performance
4	with	_	with	_	IN	2	_	_	_	_	_	_	_	I-Performance
5	controlled	_	controlled	_	JJ	2	_	_	_	_	_	_	_	I-Performance
6	drug	_	drug	_	NN	2	_	_	_	_	_	_	_	I-Performance
7	release	_	release	_	NN	2	_	_	_	_	_	_	_	I-Performance
8	has	_	have	_	VBZ	2	_	_	_	_	_	_	_	I-Performance
9	a	_	a	_	DT	2	_	_	_	_	_	_	_	I-Performance
10	pivotal	_	UNK	_	JJ	2	_	_	_	_	_	_	_	I-Performance
11	role	_	role	_	NN	2	_	_	_	_	_	role.n	Performers_and_roles	O
12	in	_	in	_	IN	2	_	_	_	_	_	_	_	B-Performance
13	the	_	the	_	DT	2	_	_	_	_	_	_	_	I-Performance
14	future	_	future	_	NN	2	_	_	_	_	_	_	_	I-Performance
15	of	_	of	_	IN	2	_	_	_	_	_	_	_	I-Performance
16	personalized	_	UNK	_	JJ	2	_	_	_	_	_	_	_	I-Performance
17	medicine	_	medicine	_	NN	2	_	_	_	_	_	_	_	I-Performance
18	.	_	.	_	.	2	_	_	_	_	_	_	_	I-Performance

1	targeted	_	UNK	_	VBN	2	_	_	_	_	_	_	_	B-Landmark_event
2	delivery	_	delivery	_	NN	2	_	_	_	_	_	_	_	I-Landmark_event
3	combined	_	combine	_	VBN	2	_	_	_	_	_	_	_	I-Landmark_event
4	with	_	with	_	IN	2	_	_	_	_	_	_	_	I-Landmark_event
5	controlled	_	controlled	_	JJ	2	_	_	_	_	_	_	_	I-Landmark_event
6	drug	_	drug	_	NN	2	_	_	_	_	_	_	_	I-Landmark_event
7	release	_	release	_	NN	2	_	_	_	_	_	_	_	I-Landmark_event
8	has	_	have	_	VBZ	2	_	_	_	_	_	_	_	I-Landmark_event
9	a	_	a	_	DT	2	_	_	_	_	_	_	_	I-Landmark_event
10	pivotal	_	UNK	_	JJ	2	_	_	_	_	_	_	_	I-Landmark_event
11	role	_	role	_	NN	2	_	_	_	_	_	_	_	I-Landmark_event
12	in	_	in	_	IN	2	_	_	_	_	_	_	_	I-Landmark_event
13	the	_	the	_	DT	2	_	_	_	_	_	_	_	I-Landmark_event
14	future	_	future	_	NN	2	_	_	_	_	_	future.n	Temporal_collocation	O
15	of	_	of	_	IN	2	_	_	_	_	_	_	_	B-Trajector_event
16	personalized	_	UNK	_	JJ	2	_	_	_	_	_	_	_	I-Trajector_event
17	medicine	_	medicine	_	NN	2	_	_	_	_	_	_	_	I-Trajector_event
18	.	_	.	_	.	2	_	_	_	_	_	_	_	I-Trajector_event

1	targeted	_	UNK	_	VBN	2	_	_	_	_	_	_	_	B-Age
2	delivery	_	delivery	_	NN	2	_	_	_	_	_	_	_	I-Age
3	combined	_	combine	_	VBN	2	_	_	_	_	_	_	_	I-Age
4	with	_	with	_	IN	2	_	_	_	_	_	_	_	I-Age
5	controlled	_	controlled	_	JJ	2	_	_	_	_	_	_	_	I-Age
6	drug	_	drug	_	NN	2	_	_	_	_	_	_	_	I-Age
7	release	_	release	_	NN	2	_	_	_	_	_	_	_	I-Age
8	has	_	have	_	VBZ	2	_	_	_	_	_	_	_	I-Age
9	a	_	a	_	DT	2	_	_	_	_	_	_	_	I-Age
10	pivotal	_	UNK	_	JJ	2	_	_	_	_	_	_	_	I-Age
11	role	_	role	_	NN	2	_	_	_	_	_	_	_	I-Age
12	in	_	in	_	IN	2	_	_	_	_	_	_	_	I-Age
13	the	_	the	_	DT	2	_	_	_	_	_	_	_	I-Age
14	future	_	future	_	NN	2	_	_	_	_	_	_	_	I-Age
15	of	_	of	_	IN	2	_	_	_	_	_	of.prep	Age	S-Degree
16	personalized	_	UNK	_	JJ	2	_	_	_	_	_	_	_	B-Age
17	medicine	_	medicine	_	NN	2	_	_	_	_	_	_	_	I-Age
18	.	_	.	_	.	2	_	_	_	_	_	_	_	I-Age

1	targeted	_	UNK	_	VBN	2	_	_	_	_	_	_	_	O
2	delivery	_	delivery	_	NN	2	_	_	_	_	_	_	_	O
3	combined	_	combine	_	VBN	2	_	_	_	_	_	_	_	O
4	with	_	with	_	IN	2	_	_	_	_	_	_	_	O
5	controlled	_	controlled	_	JJ	2	_	_	_	_	_	_	_	O
6	drug	_	drug	_	NN	2	_	_	_	_	_	_	_	O
7	release	_	release	_	NN	2	_	_	_	_	_	_	_	O
8	has	_	have	_	VBZ	2	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	2	_	_	_	_	_	_	_	O
10	pivotal	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
11	role	_	role	_	NN	2	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	2	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
14	future	_	future	_	NN	2	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
16	personalized	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
17	medicine	_	medicine	_	NN	2	_	_	_	_	_	medicine.n	Medical_specialties	O
18	.	_	.	_	.	2	_	_	_	_	_	_	_	S-Type

1	this	_	This	_	DT	3	_	_	_	_	_	_	_	B-Age
2	review	_	review	_	NN	3	_	_	_	_	_	_	_	I-Age
3	covets	_	UNK	_	VBZ	3	_	_	_	_	_	_	_	I-Age
4	the	_	the	_	DT	3	_	_	_	_	_	_	_	I-Age
5	principles	_	principle	_	NNS	3	_	_	_	_	_	_	_	I-Age
6	,	_	,	_	,	3	_	_	_	_	_	_	_	I-Age
7	advantages	_	advantage	_	NNS	3	_	_	_	_	_	_	_	I-Age
8	,	_	,	_	,	3	_	_	_	_	_	_	_	I-Age
9	and	_	and	_	CC	3	_	_	_	_	_	_	_	I-Age
10	drawbacks	_	UNK	_	NNS	3	_	_	_	_	_	_	_	I-Age
11	of	_	of	_	IN	3	_	_	_	_	_	of.prep	Age	S-Degree
12	passive	_	UNK	_	JJ	3	_	_	_	_	_	_	_	B-Age
13	and	_	and	_	CC	3	_	_	_	_	_	_	_	I-Age
14	active	_	active	_	JJ	3	_	_	_	_	_	_	_	I-Age
15	targeting	_	UNK	_	NN	3	_	_	_	_	_	_	_	I-Age
16	based	_	base	_	VBN	3	_	_	_	_	_	_	_	I-Age
17	on	_	on	_	IN	3	_	_	_	_	_	_	_	I-Age
18	various	_	various	_	JJ	3	_	_	_	_	_	_	_	I-Age
19	polymer	_	UNK	_	NN	3	_	_	_	_	_	_	_	I-Age
20	and	_	and	_	CC	3	_	_	_	_	_	_	_	I-Age
21	magnetic	_	magnetic	_	JJ	3	_	_	_	_	_	_	_	I-Age
22	iron	_	UNK	_	NN	3	_	_	_	_	_	_	_	I-Age
23	oxide	_	oxide	_	NN	3	_	_	_	_	_	_	_	I-Age
24	nanoparticle	_	UNK	_	NN	3	_	_	_	_	_	_	_	I-Age
25	carriers	_	UNK	_	NNS	3	_	_	_	_	_	_	_	I-Age
26	with	_	with	_	IN	3	_	_	_	_	_	_	_	I-Age
27	drug	_	drug	_	NN	3	_	_	_	_	_	_	_	I-Age
28	attached	_	attach	_	VBN	3	_	_	_	_	_	_	_	I-Age
29	by	_	by	_	IN	3	_	_	_	_	_	_	_	I-Age
30	both	_	both	_	DT	3	_	_	_	_	_	_	_	I-Age
31	covalent	_	UNK	_	NN	3	_	_	_	_	_	_	_	I-Age
32	and	_	and	_	CC	3	_	_	_	_	_	_	_	I-Age
33	noncovalent	_	UNK	_	JJ	3	_	_	_	_	_	_	_	I-Age
34	pathways	_	UNK	_	NNS	3	_	_	_	_	_	_	_	I-Age
35	.	_	.	_	.	3	_	_	_	_	_	_	_	I-Age

1	this	_	This	_	DT	3	_	_	_	_	_	_	_	B-Effect
2	review	_	review	_	NN	3	_	_	_	_	_	_	_	I-Effect
3	covets	_	UNK	_	VBZ	3	_	_	_	_	_	_	_	I-Effect
4	the	_	the	_	DT	3	_	_	_	_	_	_	_	I-Effect
5	principles	_	principle	_	NNS	3	_	_	_	_	_	_	_	I-Effect
6	,	_	,	_	,	3	_	_	_	_	_	_	_	I-Effect
7	advantages	_	advantage	_	NNS	3	_	_	_	_	_	_	_	I-Effect
8	,	_	,	_	,	3	_	_	_	_	_	_	_	I-Effect
9	and	_	and	_	CC	3	_	_	_	_	_	_	_	I-Effect
10	drawbacks	_	UNK	_	NNS	3	_	_	_	_	_	_	_	I-Effect
11	of	_	of	_	IN	3	_	_	_	_	_	_	_	B-Name
12	passive	_	UNK	_	JJ	3	_	_	_	_	_	_	_	I-Name
13	and	_	and	_	CC	3	_	_	_	_	_	_	_	I-Name
14	active	_	active	_	JJ	3	_	_	_	_	_	active.a	Active_substance	O
15	targeting	_	UNK	_	NN	3	_	_	_	_	_	_	_	B-Effect
16	based	_	base	_	VBN	3	_	_	_	_	_	_	_	I-Effect
17	on	_	on	_	IN	3	_	_	_	_	_	_	_	I-Effect
18	various	_	various	_	JJ	3	_	_	_	_	_	_	_	I-Effect
19	polymer	_	UNK	_	NN	3	_	_	_	_	_	_	_	I-Effect
20	and	_	and	_	CC	3	_	_	_	_	_	_	_	I-Effect
21	magnetic	_	magnetic	_	JJ	3	_	_	_	_	_	_	_	I-Effect
22	iron	_	UNK	_	NN	3	_	_	_	_	_	_	_	I-Effect
23	oxide	_	oxide	_	NN	3	_	_	_	_	_	_	_	I-Effect
24	nanoparticle	_	UNK	_	NN	3	_	_	_	_	_	_	_	I-Effect
25	carriers	_	UNK	_	NNS	3	_	_	_	_	_	_	_	I-Effect
26	with	_	with	_	IN	3	_	_	_	_	_	_	_	I-Effect
27	drug	_	drug	_	NN	3	_	_	_	_	_	_	_	I-Effect
28	attached	_	attach	_	VBN	3	_	_	_	_	_	_	_	I-Effect
29	by	_	by	_	IN	3	_	_	_	_	_	_	_	I-Effect
30	both	_	both	_	DT	3	_	_	_	_	_	_	_	I-Effect
31	covalent	_	UNK	_	NN	3	_	_	_	_	_	_	_	I-Effect
32	and	_	and	_	CC	3	_	_	_	_	_	_	_	I-Effect
33	noncovalent	_	UNK	_	JJ	3	_	_	_	_	_	_	_	I-Effect
34	pathways	_	UNK	_	NNS	3	_	_	_	_	_	_	_	I-Effect
35	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	this	_	This	_	DT	3	_	_	_	_	_	_	_	B-Victim
2	review	_	review	_	NN	3	_	_	_	_	_	_	_	I-Victim
3	covets	_	UNK	_	VBZ	3	_	_	_	_	_	_	_	I-Victim
4	the	_	the	_	DT	3	_	_	_	_	_	_	_	I-Victim
5	principles	_	principle	_	NNS	3	_	_	_	_	_	_	_	I-Victim
6	,	_	,	_	,	3	_	_	_	_	_	_	_	I-Victim
7	advantages	_	advantage	_	NNS	3	_	_	_	_	_	_	_	I-Victim
8	,	_	,	_	,	3	_	_	_	_	_	_	_	I-Victim
9	and	_	and	_	CC	3	_	_	_	_	_	_	_	I-Victim
10	drawbacks	_	UNK	_	NNS	3	_	_	_	_	_	_	_	I-Victim
11	of	_	of	_	IN	3	_	_	_	_	_	_	_	I-Victim
12	passive	_	UNK	_	JJ	3	_	_	_	_	_	_	_	I-Victim
13	and	_	and	_	CC	3	_	_	_	_	_	_	_	I-Victim
14	active	_	active	_	JJ	3	_	_	_	_	_	_	_	I-Victim
15	targeting	_	UNK	_	NN	3	_	_	_	_	_	_	_	I-Victim
16	based	_	base	_	VBN	3	_	_	_	_	_	_	_	I-Victim
17	on	_	on	_	IN	3	_	_	_	_	_	_	_	I-Victim
18	various	_	various	_	JJ	3	_	_	_	_	_	_	_	I-Victim
19	polymer	_	UNK	_	NN	3	_	_	_	_	_	_	_	I-Victim
20	and	_	and	_	CC	3	_	_	_	_	_	_	_	I-Victim
21	magnetic	_	magnetic	_	JJ	3	_	_	_	_	_	_	_	B-Degree
22	iron	_	UNK	_	NN	3	_	_	_	_	_	_	_	I-Degree
23	oxide	_	oxide	_	NN	3	_	_	_	_	_	_	_	I-Degree
24	nanoparticle	_	UNK	_	NN	3	_	_	_	_	_	_	_	I-Degree
25	carriers	_	UNK	_	NNS	3	_	_	_	_	_	_	_	I-Degree
26	with	_	with	_	IN	3	_	_	_	_	_	_	_	I-Degree
27	drug	_	drug	_	NN	3	_	_	_	_	_	drug.n	Cause_harm	I-Degree
28	attached	_	attach	_	VBN	3	_	_	_	_	_	_	_	I-Degree
29	by	_	by	_	IN	3	_	_	_	_	_	_	_	I-Degree
30	both	_	both	_	DT	3	_	_	_	_	_	_	_	I-Degree
31	covalent	_	UNK	_	NN	3	_	_	_	_	_	_	_	I-Degree
32	and	_	and	_	CC	3	_	_	_	_	_	_	_	I-Degree
33	noncovalent	_	UNK	_	JJ	3	_	_	_	_	_	_	_	I-Degree
34	pathways	_	UNK	_	NNS	3	_	_	_	_	_	_	_	I-Degree
35	.	_	.	_	.	3	_	_	_	_	_	_	_	I-Degree

1	attention	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
2	is	_	be	_	VBZ	4	_	_	_	_	_	_	_	O
3	devoted	_	devote	_	VBN	4	_	_	_	_	_	_	_	O
4	to	_	to	_	TO	4	_	_	_	_	_	to.prep	Goal	O
5	the	_	the	_	DT	4	_	_	_	_	_	_	_	S-Time
6	tailored	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
7	conjugation	_	conjugation	_	NN	4	_	_	_	_	_	_	_	O
8	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
9	targeting	_	target	_	VBG	4	_	_	_	_	_	_	_	O
10	ligands	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
11	(	_	(	_	(	4	_	_	_	_	_	_	_	O
12	e.g.	_	e.g.	_	NN	4	_	_	_	_	_	_	_	O
13	,	_	,	_	,	4	_	_	_	_	_	_	_	O
14	enzymes	_	UNK	_	RB	4	_	_	_	_	_	_	_	O
15	,	_	,	_	,	4	_	_	_	_	_	_	_	O
16	antibodies	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
17	,	_	,	_	,	4	_	_	_	_	_	_	_	O
18	peptides	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
19	)	_	)	_	)	4	_	_	_	_	_	_	_	O
20	to	_	to	_	TO	4	_	_	_	_	_	_	_	O
21	drug	_	drug	_	NN	4	_	_	_	_	_	_	_	O
22	carrier	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
23	systems	_	system	_	NNS	4	_	_	_	_	_	_	_	O
24	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	attention	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
2	is	_	be	_	VBZ	4	_	_	_	_	_	_	_	O
3	devoted	_	devote	_	VBN	4	_	_	_	_	_	_	_	O
4	to	_	to	_	TO	4	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
6	tailored	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
7	conjugation	_	conjugation	_	NN	4	_	_	_	_	_	_	_	O
8	of	_	of	_	IN	4	_	_	_	_	_	of.prep	Age	S-Degree
9	targeting	_	target	_	VBG	4	_	_	_	_	_	_	_	B-Age
10	ligands	_	UNK	_	NNS	4	_	_	_	_	_	_	_	I-Age
11	(	_	(	_	(	4	_	_	_	_	_	_	_	I-Age
12	e.g.	_	e.g.	_	NN	4	_	_	_	_	_	_	_	I-Age
13	,	_	,	_	,	4	_	_	_	_	_	_	_	I-Age
14	enzymes	_	UNK	_	RB	4	_	_	_	_	_	_	_	I-Age
15	,	_	,	_	,	4	_	_	_	_	_	_	_	I-Age
16	antibodies	_	UNK	_	NNS	4	_	_	_	_	_	_	_	I-Age
17	,	_	,	_	,	4	_	_	_	_	_	_	_	I-Age
18	peptides	_	UNK	_	NNS	4	_	_	_	_	_	_	_	I-Age
19	)	_	)	_	)	4	_	_	_	_	_	_	_	I-Age
20	to	_	to	_	TO	4	_	_	_	_	_	_	_	I-Age
21	drug	_	drug	_	NN	4	_	_	_	_	_	_	_	I-Age
22	carrier	_	UNK	_	NN	4	_	_	_	_	_	_	_	I-Age
23	systems	_	system	_	NNS	4	_	_	_	_	_	_	_	I-Age
24	.	_	.	_	.	4	_	_	_	_	_	_	_	I-Age

1	attention	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
2	is	_	be	_	VBZ	4	_	_	_	_	_	_	_	O
3	devoted	_	devote	_	VBN	4	_	_	_	_	_	_	_	O
4	to	_	to	_	TO	4	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
6	tailored	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
7	conjugation	_	conjugation	_	NN	4	_	_	_	_	_	_	_	O
8	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
9	targeting	_	target	_	VBG	4	_	_	_	_	_	target.v	Aiming	O
10	ligands	_	UNK	_	NNS	4	_	_	_	_	_	_	_	S-Outcome
11	(	_	(	_	(	4	_	_	_	_	_	_	_	B-Instrument
12	e.g.	_	e.g.	_	NN	4	_	_	_	_	_	_	_	I-Instrument
13	,	_	,	_	,	4	_	_	_	_	_	_	_	I-Instrument
14	enzymes	_	UNK	_	RB	4	_	_	_	_	_	_	_	I-Instrument
15	,	_	,	_	,	4	_	_	_	_	_	_	_	I-Instrument
16	antibodies	_	UNK	_	NNS	4	_	_	_	_	_	_	_	I-Instrument
17	,	_	,	_	,	4	_	_	_	_	_	_	_	I-Instrument
18	peptides	_	UNK	_	NNS	4	_	_	_	_	_	_	_	I-Instrument
19	)	_	)	_	)	4	_	_	_	_	_	_	_	I-Instrument
20	to	_	to	_	TO	4	_	_	_	_	_	_	_	I-Instrument
21	drug	_	drug	_	NN	4	_	_	_	_	_	_	_	I-Instrument
22	carrier	_	UNK	_	NN	4	_	_	_	_	_	_	_	I-Instrument
23	systems	_	system	_	NNS	4	_	_	_	_	_	_	_	I-Instrument
24	.	_	.	_	.	4	_	_	_	_	_	_	_	I-Instrument

1	attention	_	UNK	_	NN	4	_	_	_	_	_	_	_	B-Time
2	is	_	be	_	VBZ	4	_	_	_	_	_	_	_	I-Time
3	devoted	_	devote	_	VBN	4	_	_	_	_	_	_	_	I-Time
4	to	_	to	_	TO	4	_	_	_	_	_	_	_	I-Time
5	the	_	the	_	DT	4	_	_	_	_	_	_	_	I-Time
6	tailored	_	UNK	_	JJ	4	_	_	_	_	_	_	_	I-Time
7	conjugation	_	conjugation	_	NN	4	_	_	_	_	_	_	_	I-Time
8	of	_	of	_	IN	4	_	_	_	_	_	_	_	I-Time
9	targeting	_	target	_	VBG	4	_	_	_	_	_	_	_	I-Time
10	ligands	_	UNK	_	NNS	4	_	_	_	_	_	_	_	I-Time
11	(	_	(	_	(	4	_	_	_	_	_	_	_	I-Time
12	e.g.	_	e.g.	_	NN	4	_	_	_	_	_	_	_	I-Time
13	,	_	,	_	,	4	_	_	_	_	_	_	_	I-Time
14	enzymes	_	UNK	_	RB	4	_	_	_	_	_	_	_	I-Time
15	,	_	,	_	,	4	_	_	_	_	_	_	_	I-Time
16	antibodies	_	UNK	_	NNS	4	_	_	_	_	_	_	_	I-Time
17	,	_	,	_	,	4	_	_	_	_	_	_	_	I-Time
18	peptides	_	UNK	_	NNS	4	_	_	_	_	_	_	_	I-Time
19	)	_	)	_	)	4	_	_	_	_	_	_	_	I-Time
20	to	_	to	_	TO	4	_	_	_	_	_	to.prep	Goal	O
21	drug	_	drug	_	NN	4	_	_	_	_	_	_	_	B-Trajector
22	carrier	_	UNK	_	NN	4	_	_	_	_	_	_	_	I-Trajector
23	systems	_	system	_	NNS	4	_	_	_	_	_	_	_	I-Trajector
24	.	_	.	_	.	4	_	_	_	_	_	_	_	I-Trajector

1	similarly	_	UNK	_	RB	5	_	_	_	_	_	_	_	B-Descriptor
2	,	_	,	_	,	5	_	_	_	_	_	_	_	I-Descriptor
3	the	_	the	_	DT	5	_	_	_	_	_	_	_	I-Descriptor
4	approaches	_	approach	_	NNS	5	_	_	_	_	_	approach.n	Means	O
5	toward	_	toward	_	IN	5	_	_	_	_	_	_	_	B-Purpose
6	controlled	_	control	_	VBN	5	_	_	_	_	_	_	_	I-Purpose
7	drug	_	drug	_	NN	5	_	_	_	_	_	_	_	I-Purpose
8	release	_	release	_	NN	5	_	_	_	_	_	_	_	I-Purpose
9	are	_	be	_	VBP	5	_	_	_	_	_	_	_	I-Purpose
10	discussed	_	discuss	_	VBN	5	_	_	_	_	_	_	_	I-Purpose
11	.	_	.	_	.	5	_	_	_	_	_	_	_	I-Purpose

1	similarly	_	UNK	_	RB	5	_	_	_	_	_	_	_	B-Degree
2	,	_	,	_	,	5	_	_	_	_	_	_	_	I-Degree
3	the	_	the	_	DT	5	_	_	_	_	_	_	_	I-Degree
4	approaches	_	approach	_	NNS	5	_	_	_	_	_	_	_	I-Degree
5	toward	_	toward	_	IN	5	_	_	_	_	_	_	_	I-Degree
6	controlled	_	control	_	VBN	5	_	_	_	_	_	control.v	Being_in_control	I-Degree
7	drug	_	drug	_	NN	5	_	_	_	_	_	_	_	S-Manner
8	release	_	release	_	NN	5	_	_	_	_	_	_	_	B-Degree
9	are	_	be	_	VBP	5	_	_	_	_	_	_	_	I-Degree
10	discussed	_	discuss	_	VBN	5	_	_	_	_	_	_	_	I-Degree
11	.	_	.	_	.	5	_	_	_	_	_	_	_	I-Degree

1	various	_	UNK	_	JJ	6	_	_	_	_	_	_	_	B-Instance
2	unk	_	UNK	_	JJ	6	_	_	_	_	_	_	_	I-Instance
3	conjugates	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Instance
4	based	_	base	_	VBN	6	_	_	_	_	_	_	_	I-Instance
5	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Instance
6	for	_	for	_	IN	6	_	_	_	_	_	_	_	I-Instance
7	example	_	example	_	NN	6	_	_	_	_	_	example.n	Instance	O
8	,	_	,	_	,	6	_	_	_	_	_	_	_	B-Type
9	on	_	on	_	IN	6	_	_	_	_	_	_	_	I-Type
10	polyethylene	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Type
11	glycol	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Type
12	(	_	(	_	(	6	_	_	_	_	_	_	_	I-Type
13	peg	_	UNK	_	NNP	6	_	_	_	_	_	_	_	I-Type
14	)	_	)	_	)	6	_	_	_	_	_	_	_	I-Type
15	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Type
16	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	I-Type
17	(	_	(	_	(	6	_	_	_	_	_	_	_	I-Type
18	unk	_	UNK	_	JJ	6	_	_	_	_	_	_	_	I-Type
19	)	_	)	_	)	6	_	_	_	_	_	_	_	I-Type
20	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Type
21	(	_	(	_	(	6	_	_	_	_	_	_	_	I-Type
22	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	I-Type
23	)	_	)	_	)	6	_	_	_	_	_	_	_	I-Type
24	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Type
25	polymeric	_	polymeric	_	JJ	6	_	_	_	_	_	_	_	I-Type
26	micelles	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Type
27	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Type
28	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
29	nanoparticle	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
30	carriers	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
31	are	_	be	_	VBP	6	_	_	_	_	_	_	_	O
32	explored	_	explore	_	VBN	6	_	_	_	_	_	_	_	O
33	with	_	with	_	IN	6	_	_	_	_	_	_	_	O
34	respect	_	respect	_	NN	6	_	_	_	_	_	_	_	O
35	to	_	to	_	TO	6	_	_	_	_	_	_	_	O
36	absorption	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
37	,	_	,	_	,	6	_	_	_	_	_	_	_	O
38	distribution	_	distribution	_	NN	6	_	_	_	_	_	_	_	O
39	,	_	,	_	,	6	_	_	_	_	_	_	_	O
40	metabolism	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
41	,	_	,	_	,	6	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
43	excretion	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
44	(	_	(	_	(	6	_	_	_	_	_	_	_	O
45	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	O
46	scheme	_	scheme	_	NN	6	_	_	_	_	_	_	_	O
47	)	_	)	_	)	6	_	_	_	_	_	_	_	O
48	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
49	administrated	_	UNK	_	VBN	6	_	_	_	_	_	_	_	O
50	drug	_	drug	_	NN	6	_	_	_	_	_	_	_	O
51	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	various	_	UNK	_	JJ	6	_	_	_	_	_	_	_	B-Topic
2	unk	_	UNK	_	JJ	6	_	_	_	_	_	_	_	I-Topic
3	conjugates	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Topic
4	based	_	base	_	VBN	6	_	_	_	_	_	_	_	I-Topic
5	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Topic
6	for	_	for	_	IN	6	_	_	_	_	_	_	_	I-Topic
7	example	_	example	_	NN	6	_	_	_	_	_	_	_	I-Topic
8	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Topic
9	on	_	on	_	IN	6	_	_	_	_	_	_	_	I-Topic
10	polyethylene	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Topic
11	glycol	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Topic
12	(	_	(	_	(	6	_	_	_	_	_	_	_	I-Topic
13	peg	_	UNK	_	NNP	6	_	_	_	_	_	_	_	I-Topic
14	)	_	)	_	)	6	_	_	_	_	_	_	_	I-Topic
15	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Topic
16	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	I-Topic
17	(	_	(	_	(	6	_	_	_	_	_	_	_	I-Topic
18	unk	_	UNK	_	JJ	6	_	_	_	_	_	_	_	I-Topic
19	)	_	)	_	)	6	_	_	_	_	_	_	_	I-Topic
20	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Topic
21	(	_	(	_	(	6	_	_	_	_	_	_	_	I-Topic
22	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	I-Topic
23	)	_	)	_	)	6	_	_	_	_	_	_	_	I-Topic
24	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Topic
25	polymeric	_	polymeric	_	JJ	6	_	_	_	_	_	_	_	I-Topic
26	micelles	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Topic
27	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Topic
28	and	_	and	_	CC	6	_	_	_	_	_	_	_	I-Topic
29	nanoparticle	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Topic
30	carriers	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Topic
31	are	_	be	_	VBP	6	_	_	_	_	_	_	_	I-Topic
32	explored	_	explore	_	VBN	6	_	_	_	_	_	_	_	I-Topic
33	with	_	with	_	IN	6	_	_	_	_	_	_	_	I-Topic
34	respect	_	respect	_	NN	6	_	_	_	_	_	respect.n	Judgment	S-Degree
35	to	_	to	_	TO	6	_	_	_	_	_	_	_	B-Manner
36	absorption	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Manner
37	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Manner
38	distribution	_	distribution	_	NN	6	_	_	_	_	_	_	_	I-Manner
39	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Manner
40	metabolism	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Manner
41	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Manner
42	and	_	and	_	CC	6	_	_	_	_	_	_	_	I-Manner
43	excretion	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Manner
44	(	_	(	_	(	6	_	_	_	_	_	_	_	I-Manner
45	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	I-Manner
46	scheme	_	scheme	_	NN	6	_	_	_	_	_	_	_	I-Manner
47	)	_	)	_	)	6	_	_	_	_	_	_	_	I-Manner
48	of	_	of	_	IN	6	_	_	_	_	_	_	_	I-Manner
49	administrated	_	UNK	_	VBN	6	_	_	_	_	_	_	_	I-Manner
50	drug	_	drug	_	NN	6	_	_	_	_	_	_	_	I-Manner
51	.	_	.	_	.	6	_	_	_	_	_	_	_	I-Manner

1	various	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
3	conjugates	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
4	based	_	base	_	VBN	6	_	_	_	_	_	_	_	O
5	,	_	,	_	,	6	_	_	_	_	_	_	_	O
6	for	_	for	_	IN	6	_	_	_	_	_	_	_	O
7	example	_	example	_	NN	6	_	_	_	_	_	_	_	O
8	,	_	,	_	,	6	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	6	_	_	_	_	_	_	_	O
10	polyethylene	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
11	glycol	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
12	(	_	(	_	(	6	_	_	_	_	_	_	_	O
13	peg	_	UNK	_	NNP	6	_	_	_	_	_	_	_	O
14	)	_	)	_	)	6	_	_	_	_	_	_	_	O
15	,	_	,	_	,	6	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	O
17	(	_	(	_	(	6	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
19	)	_	)	_	)	6	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
21	(	_	(	_	(	6	_	_	_	_	_	_	_	B-Time
22	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	I-Time
23	)	_	)	_	)	6	_	_	_	_	_	_	_	I-Time
24	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Time
25	polymeric	_	polymeric	_	JJ	6	_	_	_	_	_	_	_	I-Time
26	micelles	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Time
27	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Time
28	and	_	and	_	CC	6	_	_	_	_	_	_	_	I-Time
29	nanoparticle	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Time
30	carriers	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Time
31	are	_	be	_	VBP	6	_	_	_	_	_	_	_	I-Time
32	explored	_	explore	_	VBN	6	_	_	_	_	_	_	_	I-Time
33	with	_	with	_	IN	6	_	_	_	_	_	_	_	I-Time
34	respect	_	respect	_	NN	6	_	_	_	_	_	_	_	I-Time
35	to	_	to	_	TO	6	_	_	_	_	_	to.prep	Goal	O
36	absorption	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
37	,	_	,	_	,	6	_	_	_	_	_	_	_	O
38	distribution	_	distribution	_	NN	6	_	_	_	_	_	_	_	O
39	,	_	,	_	,	6	_	_	_	_	_	_	_	O
40	metabolism	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
41	,	_	,	_	,	6	_	_	_	_	_	_	_	O
42	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
43	excretion	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
44	(	_	(	_	(	6	_	_	_	_	_	_	_	O
45	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	O
46	scheme	_	scheme	_	NN	6	_	_	_	_	_	_	_	O
47	)	_	)	_	)	6	_	_	_	_	_	_	_	O
48	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
49	administrated	_	UNK	_	VBN	6	_	_	_	_	_	_	_	O
50	drug	_	drug	_	NN	6	_	_	_	_	_	_	_	O
51	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	various	_	UNK	_	JJ	6	_	_	_	_	_	_	_	B-Manner
2	unk	_	UNK	_	JJ	6	_	_	_	_	_	_	_	I-Manner
3	conjugates	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Manner
4	based	_	base	_	VBN	6	_	_	_	_	_	_	_	I-Manner
5	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Manner
6	for	_	for	_	IN	6	_	_	_	_	_	_	_	I-Manner
7	example	_	example	_	NN	6	_	_	_	_	_	_	_	I-Manner
8	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Manner
9	on	_	on	_	IN	6	_	_	_	_	_	_	_	I-Manner
10	polyethylene	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Manner
11	glycol	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Manner
12	(	_	(	_	(	6	_	_	_	_	_	_	_	I-Manner
13	peg	_	UNK	_	NNP	6	_	_	_	_	_	_	_	I-Manner
14	)	_	)	_	)	6	_	_	_	_	_	_	_	I-Manner
15	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Manner
16	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	I-Manner
17	(	_	(	_	(	6	_	_	_	_	_	_	_	I-Manner
18	unk	_	UNK	_	JJ	6	_	_	_	_	_	_	_	I-Manner
19	)	_	)	_	)	6	_	_	_	_	_	_	_	I-Manner
20	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Manner
21	(	_	(	_	(	6	_	_	_	_	_	_	_	I-Manner
22	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	I-Manner
23	)	_	)	_	)	6	_	_	_	_	_	_	_	I-Manner
24	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Manner
25	polymeric	_	polymeric	_	JJ	6	_	_	_	_	_	_	_	I-Manner
26	micelles	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Manner
27	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Manner
28	and	_	and	_	CC	6	_	_	_	_	_	_	_	I-Manner
29	nanoparticle	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Manner
30	carriers	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Manner
31	are	_	be	_	VBP	6	_	_	_	_	_	_	_	I-Manner
32	explored	_	explore	_	VBN	6	_	_	_	_	_	_	_	I-Manner
33	with	_	with	_	IN	6	_	_	_	_	_	_	_	I-Manner
34	respect	_	respect	_	NN	6	_	_	_	_	_	_	_	I-Manner
35	to	_	to	_	TO	6	_	_	_	_	_	_	_	I-Manner
36	absorption	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Manner
37	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Manner
38	distribution	_	distribution	_	NN	6	_	_	_	_	_	distribution.n	Dispersal	S-Cause
39	,	_	,	_	,	6	_	_	_	_	_	_	_	B-Manner
40	metabolism	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Manner
41	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Manner
42	and	_	and	_	CC	6	_	_	_	_	_	_	_	I-Manner
43	excretion	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Manner
44	(	_	(	_	(	6	_	_	_	_	_	_	_	I-Manner
45	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	I-Manner
46	scheme	_	scheme	_	NN	6	_	_	_	_	_	_	_	I-Manner
47	)	_	)	_	)	6	_	_	_	_	_	_	_	I-Manner
48	of	_	of	_	IN	6	_	_	_	_	_	_	_	I-Manner
49	administrated	_	UNK	_	VBN	6	_	_	_	_	_	_	_	I-Manner
50	drug	_	drug	_	NN	6	_	_	_	_	_	_	_	I-Manner
51	.	_	.	_	.	6	_	_	_	_	_	_	_	I-Manner

1	various	_	UNK	_	JJ	6	_	_	_	_	_	_	_	B-Manner
2	unk	_	UNK	_	JJ	6	_	_	_	_	_	_	_	I-Manner
3	conjugates	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Manner
4	based	_	base	_	VBN	6	_	_	_	_	_	_	_	I-Manner
5	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Manner
6	for	_	for	_	IN	6	_	_	_	_	_	_	_	I-Manner
7	example	_	example	_	NN	6	_	_	_	_	_	_	_	I-Manner
8	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Manner
9	on	_	on	_	IN	6	_	_	_	_	_	_	_	I-Manner
10	polyethylene	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Manner
11	glycol	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Manner
12	(	_	(	_	(	6	_	_	_	_	_	_	_	I-Manner
13	peg	_	UNK	_	NNP	6	_	_	_	_	_	_	_	I-Manner
14	)	_	)	_	)	6	_	_	_	_	_	_	_	I-Manner
15	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Manner
16	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	I-Manner
17	(	_	(	_	(	6	_	_	_	_	_	_	_	I-Manner
18	unk	_	UNK	_	JJ	6	_	_	_	_	_	_	_	I-Manner
19	)	_	)	_	)	6	_	_	_	_	_	_	_	I-Manner
20	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Manner
21	(	_	(	_	(	6	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	O
23	)	_	)	_	)	6	_	_	_	_	_	_	_	O
24	,	_	,	_	,	6	_	_	_	_	_	_	_	O
25	polymeric	_	polymeric	_	JJ	6	_	_	_	_	_	_	_	O
26	micelles	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
27	,	_	,	_	,	6	_	_	_	_	_	_	_	O
28	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
29	nanoparticle	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
30	carriers	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
31	are	_	be	_	VBP	6	_	_	_	_	_	_	_	O
32	explored	_	explore	_	VBN	6	_	_	_	_	_	_	_	O
33	with	_	with	_	IN	6	_	_	_	_	_	_	_	O
34	respect	_	respect	_	NN	6	_	_	_	_	_	_	_	O
35	to	_	to	_	TO	6	_	_	_	_	_	_	_	O
36	absorption	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
37	,	_	,	_	,	6	_	_	_	_	_	_	_	O
38	distribution	_	distribution	_	NN	6	_	_	_	_	_	_	_	O
39	,	_	,	_	,	6	_	_	_	_	_	_	_	O
40	metabolism	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
41	,	_	,	_	,	6	_	_	_	_	_	_	_	B-Name
42	and	_	and	_	CC	6	_	_	_	_	_	_	_	I-Name
43	excretion	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Name
44	(	_	(	_	(	6	_	_	_	_	_	_	_	I-Name
45	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	I-Name
46	scheme	_	scheme	_	NN	6	_	_	_	_	_	scheme.n	Project	O
47	)	_	)	_	)	6	_	_	_	_	_	_	_	B-Name
48	of	_	of	_	IN	6	_	_	_	_	_	_	_	I-Name
49	administrated	_	UNK	_	VBN	6	_	_	_	_	_	_	_	I-Name
50	drug	_	drug	_	NN	6	_	_	_	_	_	_	_	I-Name
51	.	_	.	_	.	6	_	_	_	_	_	_	_	I-Name

1	various	_	UNK	_	JJ	6	_	_	_	_	_	_	_	B-Age
2	unk	_	UNK	_	JJ	6	_	_	_	_	_	_	_	I-Age
3	conjugates	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Age
4	based	_	base	_	VBN	6	_	_	_	_	_	_	_	I-Age
5	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Age
6	for	_	for	_	IN	6	_	_	_	_	_	_	_	I-Age
7	example	_	example	_	NN	6	_	_	_	_	_	_	_	I-Age
8	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Age
9	on	_	on	_	IN	6	_	_	_	_	_	_	_	I-Age
10	polyethylene	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Age
11	glycol	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Age
12	(	_	(	_	(	6	_	_	_	_	_	_	_	I-Age
13	peg	_	UNK	_	NNP	6	_	_	_	_	_	_	_	I-Age
14	)	_	)	_	)	6	_	_	_	_	_	_	_	I-Age
15	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Age
16	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	I-Age
17	(	_	(	_	(	6	_	_	_	_	_	_	_	I-Age
18	unk	_	UNK	_	JJ	6	_	_	_	_	_	_	_	I-Age
19	)	_	)	_	)	6	_	_	_	_	_	_	_	I-Age
20	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Age
21	(	_	(	_	(	6	_	_	_	_	_	_	_	I-Age
22	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	I-Age
23	)	_	)	_	)	6	_	_	_	_	_	_	_	I-Age
24	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Age
25	polymeric	_	polymeric	_	JJ	6	_	_	_	_	_	_	_	I-Age
26	micelles	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Age
27	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Age
28	and	_	and	_	CC	6	_	_	_	_	_	_	_	I-Age
29	nanoparticle	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Age
30	carriers	_	UNK	_	NNS	6	_	_	_	_	_	_	_	I-Age
31	are	_	be	_	VBP	6	_	_	_	_	_	_	_	I-Age
32	explored	_	explore	_	VBN	6	_	_	_	_	_	_	_	I-Age
33	with	_	with	_	IN	6	_	_	_	_	_	_	_	I-Age
34	respect	_	respect	_	NN	6	_	_	_	_	_	_	_	I-Age
35	to	_	to	_	TO	6	_	_	_	_	_	_	_	I-Age
36	absorption	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Age
37	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Age
38	distribution	_	distribution	_	NN	6	_	_	_	_	_	_	_	I-Age
39	,	_	,	_	,	6	_	_	_	_	_	_	_	I-Age
40	metabolism	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Age
41	,	_	,	_	,	6	_	_	_	_	_	_	_	B-Degree
42	and	_	and	_	CC	6	_	_	_	_	_	_	_	I-Degree
43	excretion	_	UNK	_	NN	6	_	_	_	_	_	_	_	I-Degree
44	(	_	(	_	(	6	_	_	_	_	_	_	_	I-Degree
45	unk	_	UNK	_	NNP	6	_	_	_	_	_	_	_	I-Degree
46	scheme	_	scheme	_	NN	6	_	_	_	_	_	_	_	I-Degree
47	)	_	)	_	)	6	_	_	_	_	_	_	_	I-Degree
48	of	_	of	_	IN	6	_	_	_	_	_	of.prep	Age	I-Degree
49	administrated	_	UNK	_	VBN	6	_	_	_	_	_	_	_	I-Degree
50	drug	_	drug	_	NN	6	_	_	_	_	_	_	_	I-Degree
51	.	_	.	_	.	6	_	_	_	_	_	_	_	I-Degree

1	design	_	UNK	_	NN	7	_	_	_	_	_	_	_	B-Descriptor
2	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Descriptor
3	structure	_	structure	_	NN	7	_	_	_	_	_	_	_	I-Descriptor
4	of	_	of	_	IN	7	_	_	_	_	_	of.prep	Age	S-Degree
5	superparamagnetic	_	UNK	_	JJ	7	_	_	_	_	_	_	_	B-Age
6	iron	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Age
7	oxide	_	oxide	_	NN	7	_	_	_	_	_	_	_	I-Age
8	nanoparticles	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Age
9	(	_	(	_	(	7	_	_	_	_	_	_	_	I-Age
10	spion	_	UNK	_	NNP	7	_	_	_	_	_	_	_	I-Age
11	)	_	)	_	)	7	_	_	_	_	_	_	_	I-Age
12	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Age
13	condensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	I-Age
14	magnetic	_	magnetic	_	JJ	7	_	_	_	_	_	_	_	I-Age
15	clusters	_	cluster	_	NNS	7	_	_	_	_	_	_	_	I-Age
16	are	_	be	_	VBP	7	_	_	_	_	_	_	_	I-Age
17	classified	_	classify	_	VBN	7	_	_	_	_	_	_	_	I-Age
18	according	_	accord	_	VBG	7	_	_	_	_	_	_	_	I-Age
19	to	_	to	_	TO	7	_	_	_	_	_	_	_	I-Age
20	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Age
21	mechanism	_	mechanism	_	NN	7	_	_	_	_	_	_	_	I-Age
22	of	_	of	_	IN	7	_	_	_	_	_	_	_	I-Age
23	noncovalent	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Age
24	drug	_	drug	_	NN	7	_	_	_	_	_	_	_	I-Age
25	loading	_	load	_	VBG	7	_	_	_	_	_	_	_	I-Age
26	involving	_	involve	_	VBG	7	_	_	_	_	_	_	_	I-Age
27	hydrophobic	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Age
28	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Age
29	electrostatic	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Age
30	interactions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Age
31	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Age
32	coordination	_	coordination	_	NN	7	_	_	_	_	_	_	_	I-Age
33	chemistry	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Age
34	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Age
35	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Age
36	encapsulation	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Age
37	in	_	in	_	IN	7	_	_	_	_	_	_	_	I-Age
38	porous	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Age
39	materials	_	material	_	NNS	7	_	_	_	_	_	_	_	I-Age
40	.	_	.	_	.	7	_	_	_	_	_	_	_	I-Age

1	design	_	UNK	_	NN	7	_	_	_	_	_	_	_	B-Individuals
2	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Individuals
3	structure	_	structure	_	NN	7	_	_	_	_	_	_	_	I-Individuals
4	of	_	of	_	IN	7	_	_	_	_	_	_	_	I-Individuals
5	superparamagnetic	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Individuals
6	iron	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Individuals
7	oxide	_	oxide	_	NN	7	_	_	_	_	_	_	_	I-Individuals
8	nanoparticles	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Individuals
9	(	_	(	_	(	7	_	_	_	_	_	_	_	I-Individuals
10	spion	_	UNK	_	NNP	7	_	_	_	_	_	_	_	I-Individuals
11	)	_	)	_	)	7	_	_	_	_	_	_	_	I-Individuals
12	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Individuals
13	condensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	I-Individuals
14	magnetic	_	magnetic	_	JJ	7	_	_	_	_	_	_	_	I-Individuals
15	clusters	_	cluster	_	NNS	7	_	_	_	_	_	cluster.n	Aggregate	I-Individuals
16	are	_	be	_	VBP	7	_	_	_	_	_	_	_	I-Individuals
17	classified	_	classify	_	VBN	7	_	_	_	_	_	_	_	I-Individuals
18	according	_	accord	_	VBG	7	_	_	_	_	_	_	_	I-Individuals
19	to	_	to	_	TO	7	_	_	_	_	_	_	_	I-Individuals
20	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Individuals
21	mechanism	_	mechanism	_	NN	7	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
23	noncovalent	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
24	drug	_	drug	_	NN	7	_	_	_	_	_	_	_	O
25	loading	_	load	_	VBG	7	_	_	_	_	_	_	_	O
26	involving	_	involve	_	VBG	7	_	_	_	_	_	_	_	O
27	hydrophobic	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
28	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
29	electrostatic	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
30	interactions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
31	,	_	,	_	,	7	_	_	_	_	_	_	_	O
32	coordination	_	coordination	_	NN	7	_	_	_	_	_	_	_	O
33	chemistry	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
34	,	_	,	_	,	7	_	_	_	_	_	_	_	O
35	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
36	encapsulation	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	7	_	_	_	_	_	_	_	O
38	porous	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
39	materials	_	material	_	NNS	7	_	_	_	_	_	_	_	O
40	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	design	_	UNK	_	NN	7	_	_	_	_	_	_	_	B-Topic
2	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Topic
3	structure	_	structure	_	NN	7	_	_	_	_	_	_	_	I-Topic
4	of	_	of	_	IN	7	_	_	_	_	_	_	_	I-Topic
5	superparamagnetic	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Topic
6	iron	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Topic
7	oxide	_	oxide	_	NN	7	_	_	_	_	_	_	_	I-Topic
8	nanoparticles	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Topic
9	(	_	(	_	(	7	_	_	_	_	_	_	_	I-Topic
10	spion	_	UNK	_	NNP	7	_	_	_	_	_	_	_	I-Topic
11	)	_	)	_	)	7	_	_	_	_	_	_	_	I-Topic
12	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Topic
13	condensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	I-Topic
14	magnetic	_	magnetic	_	JJ	7	_	_	_	_	_	_	_	I-Topic
15	clusters	_	cluster	_	NNS	7	_	_	_	_	_	_	_	I-Topic
16	are	_	be	_	VBP	7	_	_	_	_	_	_	_	I-Topic
17	classified	_	classify	_	VBN	7	_	_	_	_	_	_	_	I-Topic
18	according	_	accord	_	VBG	7	_	_	_	_	_	accord.v	Be_in_agreement_on_action	S-Degree
19	to	_	to	_	TO	7	_	_	_	_	_	_	_	B-Parties
20	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Parties
21	mechanism	_	mechanism	_	NN	7	_	_	_	_	_	_	_	B-Degree
22	of	_	of	_	IN	7	_	_	_	_	_	_	_	I-Degree
23	noncovalent	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Degree
24	drug	_	drug	_	NN	7	_	_	_	_	_	_	_	I-Degree
25	loading	_	load	_	VBG	7	_	_	_	_	_	_	_	I-Degree
26	involving	_	involve	_	VBG	7	_	_	_	_	_	_	_	I-Degree
27	hydrophobic	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Degree
28	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Degree
29	electrostatic	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Degree
30	interactions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Degree
31	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Degree
32	coordination	_	coordination	_	NN	7	_	_	_	_	_	_	_	I-Degree
33	chemistry	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Degree
34	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Degree
35	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Degree
36	encapsulation	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Degree
37	in	_	in	_	IN	7	_	_	_	_	_	_	_	I-Degree
38	porous	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Degree
39	materials	_	material	_	NNS	7	_	_	_	_	_	_	_	I-Degree
40	.	_	.	_	.	7	_	_	_	_	_	_	_	I-Degree

1	design	_	UNK	_	NN	7	_	_	_	_	_	_	_	B-Trajector
2	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Trajector
3	structure	_	structure	_	NN	7	_	_	_	_	_	_	_	I-Trajector
4	of	_	of	_	IN	7	_	_	_	_	_	_	_	I-Trajector
5	superparamagnetic	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Trajector
6	iron	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Trajector
7	oxide	_	oxide	_	NN	7	_	_	_	_	_	_	_	I-Trajector
8	nanoparticles	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Trajector
9	(	_	(	_	(	7	_	_	_	_	_	_	_	I-Trajector
10	spion	_	UNK	_	NNP	7	_	_	_	_	_	_	_	I-Trajector
11	)	_	)	_	)	7	_	_	_	_	_	_	_	I-Trajector
12	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Trajector
13	condensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	I-Trajector
14	magnetic	_	magnetic	_	JJ	7	_	_	_	_	_	_	_	I-Trajector
15	clusters	_	cluster	_	NNS	7	_	_	_	_	_	_	_	I-Trajector
16	are	_	be	_	VBP	7	_	_	_	_	_	_	_	I-Trajector
17	classified	_	classify	_	VBN	7	_	_	_	_	_	_	_	I-Trajector
18	according	_	accord	_	VBG	7	_	_	_	_	_	_	_	I-Trajector
19	to	_	to	_	TO	7	_	_	_	_	_	to.prep	Goal	I-Trajector
20	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Trajector
21	mechanism	_	mechanism	_	NN	7	_	_	_	_	_	_	_	O
22	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
23	noncovalent	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
24	drug	_	drug	_	NN	7	_	_	_	_	_	_	_	O
25	loading	_	load	_	VBG	7	_	_	_	_	_	_	_	O
26	involving	_	involve	_	VBG	7	_	_	_	_	_	_	_	O
27	hydrophobic	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
28	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
29	electrostatic	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
30	interactions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
31	,	_	,	_	,	7	_	_	_	_	_	_	_	O
32	coordination	_	coordination	_	NN	7	_	_	_	_	_	_	_	O
33	chemistry	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
34	,	_	,	_	,	7	_	_	_	_	_	_	_	O
35	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
36	encapsulation	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
37	in	_	in	_	IN	7	_	_	_	_	_	_	_	O
38	porous	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
39	materials	_	material	_	NNS	7	_	_	_	_	_	_	_	O
40	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	design	_	UNK	_	NN	7	_	_	_	_	_	_	_	B-Age
2	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Age
3	structure	_	structure	_	NN	7	_	_	_	_	_	_	_	I-Age
4	of	_	of	_	IN	7	_	_	_	_	_	_	_	I-Age
5	superparamagnetic	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Age
6	iron	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Age
7	oxide	_	oxide	_	NN	7	_	_	_	_	_	_	_	I-Age
8	nanoparticles	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Age
9	(	_	(	_	(	7	_	_	_	_	_	_	_	I-Age
10	spion	_	UNK	_	NNP	7	_	_	_	_	_	_	_	I-Age
11	)	_	)	_	)	7	_	_	_	_	_	_	_	I-Age
12	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Age
13	condensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	I-Age
14	magnetic	_	magnetic	_	JJ	7	_	_	_	_	_	_	_	I-Age
15	clusters	_	cluster	_	NNS	7	_	_	_	_	_	_	_	I-Age
16	are	_	be	_	VBP	7	_	_	_	_	_	_	_	I-Age
17	classified	_	classify	_	VBN	7	_	_	_	_	_	_	_	I-Age
18	according	_	accord	_	VBG	7	_	_	_	_	_	_	_	I-Age
19	to	_	to	_	TO	7	_	_	_	_	_	_	_	I-Age
20	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Age
21	mechanism	_	mechanism	_	NN	7	_	_	_	_	_	_	_	I-Age
22	of	_	of	_	IN	7	_	_	_	_	_	of.prep	Age	I-Age
23	noncovalent	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Age
24	drug	_	drug	_	NN	7	_	_	_	_	_	_	_	I-Age
25	loading	_	load	_	VBG	7	_	_	_	_	_	_	_	I-Age
26	involving	_	involve	_	VBG	7	_	_	_	_	_	_	_	I-Age
27	hydrophobic	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Age
28	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Age
29	electrostatic	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Age
30	interactions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Age
31	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Age
32	coordination	_	coordination	_	NN	7	_	_	_	_	_	_	_	I-Age
33	chemistry	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Age
34	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Age
35	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Age
36	encapsulation	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Age
37	in	_	in	_	IN	7	_	_	_	_	_	_	_	I-Age
38	porous	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Age
39	materials	_	material	_	NNS	7	_	_	_	_	_	_	_	I-Age
40	.	_	.	_	.	7	_	_	_	_	_	_	_	I-Age

1	design	_	UNK	_	NN	7	_	_	_	_	_	_	_	B-Degree
2	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Degree
3	structure	_	structure	_	NN	7	_	_	_	_	_	_	_	I-Degree
4	of	_	of	_	IN	7	_	_	_	_	_	_	_	I-Degree
5	superparamagnetic	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Degree
6	iron	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Degree
7	oxide	_	oxide	_	NN	7	_	_	_	_	_	_	_	I-Degree
8	nanoparticles	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Degree
9	(	_	(	_	(	7	_	_	_	_	_	_	_	I-Degree
10	spion	_	UNK	_	NNP	7	_	_	_	_	_	_	_	I-Degree
11	)	_	)	_	)	7	_	_	_	_	_	_	_	I-Degree
12	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Degree
13	condensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	I-Degree
14	magnetic	_	magnetic	_	JJ	7	_	_	_	_	_	_	_	I-Degree
15	clusters	_	cluster	_	NNS	7	_	_	_	_	_	_	_	I-Degree
16	are	_	be	_	VBP	7	_	_	_	_	_	_	_	I-Degree
17	classified	_	classify	_	VBN	7	_	_	_	_	_	_	_	I-Degree
18	according	_	accord	_	VBG	7	_	_	_	_	_	_	_	I-Degree
19	to	_	to	_	TO	7	_	_	_	_	_	_	_	I-Degree
20	the	_	the	_	DT	7	_	_	_	_	_	_	_	I-Degree
21	mechanism	_	mechanism	_	NN	7	_	_	_	_	_	_	_	I-Degree
22	of	_	of	_	IN	7	_	_	_	_	_	_	_	B-Time
23	noncovalent	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Time
24	drug	_	drug	_	NN	7	_	_	_	_	_	_	_	I-Time
25	loading	_	load	_	VBG	7	_	_	_	_	_	load.v	Placing	S-Degree
26	involving	_	involve	_	VBG	7	_	_	_	_	_	_	_	B-Source
27	hydrophobic	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Source
28	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Source
29	electrostatic	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Source
30	interactions	_	UNK	_	NNS	7	_	_	_	_	_	_	_	I-Source
31	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Source
32	coordination	_	coordination	_	NN	7	_	_	_	_	_	_	_	I-Source
33	chemistry	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Source
34	,	_	,	_	,	7	_	_	_	_	_	_	_	I-Source
35	and	_	and	_	CC	7	_	_	_	_	_	_	_	I-Source
36	encapsulation	_	UNK	_	NN	7	_	_	_	_	_	_	_	I-Source
37	in	_	in	_	IN	7	_	_	_	_	_	_	_	I-Source
38	porous	_	UNK	_	JJ	7	_	_	_	_	_	_	_	I-Source
39	materials	_	material	_	NNS	7	_	_	_	_	_	_	_	B-Degree
40	.	_	.	_	.	7	_	_	_	_	_	_	_	I-Degree

1	principles	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	8	_	_	_	_	_	of.prep	Age	S-Degree
3	covalent	_	UNK	_	JJ	8	_	_	_	_	_	_	_	B-Age
4	conjugation	_	conjugation	_	NN	8	_	_	_	_	_	_	_	I-Age
5	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Age
6	drugs	_	drug	_	NNS	8	_	_	_	_	_	_	_	I-Age
7	with	_	with	_	IN	8	_	_	_	_	_	_	_	I-Age
8	unk	_	UNK	_	NNP	8	_	_	_	_	_	_	_	I-Age
9	including	_	include	_	VBG	8	_	_	_	_	_	_	_	I-Age
10	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
11	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Age
12	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
13	bonds	_	bond	_	NNS	8	_	_	_	_	_	_	_	I-Age
14	,	_	,	_	,	8	_	_	_	_	_	_	_	I-Age
15	amide	_	UNK	_	RB	8	_	_	_	_	_	_	_	I-Age
16	linkage	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Age
17	,	_	,	_	,	8	_	_	_	_	_	_	_	I-Age
18	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
19	bonds	_	bond	_	NNS	8	_	_	_	_	_	_	_	I-Age
20	,	_	,	_	,	8	_	_	_	_	_	_	_	I-Age
21	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Age
22	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
23	bonds	_	bond	_	NNS	8	_	_	_	_	_	_	_	I-Age
24	are	_	be	_	VBP	8	_	_	_	_	_	_	_	I-Age
25	also	_	also	_	RB	8	_	_	_	_	_	_	_	I-Age
26	thoroughly	_	UNK	_	RB	8	_	_	_	_	_	_	_	I-Age
27	described	_	describe	_	VBN	8	_	_	_	_	_	_	_	I-Age
28	.	_	.	_	.	8	_	_	_	_	_	_	_	I-Age

1	principles	_	UNK	_	NNS	8	_	_	_	_	_	_	_	B-Age
2	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Age
3	covalent	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
4	conjugation	_	conjugation	_	NN	8	_	_	_	_	_	_	_	I-Age
5	of	_	of	_	IN	8	_	_	_	_	_	of.prep	Age	S-Degree
6	drugs	_	drug	_	NNS	8	_	_	_	_	_	_	_	B-Duration
7	with	_	with	_	IN	8	_	_	_	_	_	_	_	I-Duration
8	unk	_	UNK	_	NNP	8	_	_	_	_	_	_	_	I-Duration
9	including	_	include	_	VBG	8	_	_	_	_	_	_	_	B-Age
10	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
11	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Age
12	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
13	bonds	_	bond	_	NNS	8	_	_	_	_	_	_	_	I-Age
14	,	_	,	_	,	8	_	_	_	_	_	_	_	I-Age
15	amide	_	UNK	_	RB	8	_	_	_	_	_	_	_	I-Age
16	linkage	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Age
17	,	_	,	_	,	8	_	_	_	_	_	_	_	I-Age
18	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
19	bonds	_	bond	_	NNS	8	_	_	_	_	_	_	_	I-Age
20	,	_	,	_	,	8	_	_	_	_	_	_	_	I-Age
21	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Age
22	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Age
23	bonds	_	bond	_	NNS	8	_	_	_	_	_	_	_	I-Age
24	are	_	be	_	VBP	8	_	_	_	_	_	_	_	I-Age
25	also	_	also	_	RB	8	_	_	_	_	_	_	_	I-Age
26	thoroughly	_	UNK	_	RB	8	_	_	_	_	_	_	_	I-Age
27	described	_	describe	_	VBN	8	_	_	_	_	_	_	_	I-Age
28	.	_	.	_	.	8	_	_	_	_	_	_	_	I-Age

1	principles	_	UNK	_	NNS	8	_	_	_	_	_	_	_	B-Victim
2	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Victim
3	covalent	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Victim
4	conjugation	_	conjugation	_	NN	8	_	_	_	_	_	_	_	I-Victim
5	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Victim
6	drugs	_	drug	_	NNS	8	_	_	_	_	_	drug.n	Cause_harm	S-Degree
7	with	_	with	_	IN	8	_	_	_	_	_	_	_	B-Purpose
8	unk	_	UNK	_	NNP	8	_	_	_	_	_	_	_	I-Purpose
9	including	_	include	_	VBG	8	_	_	_	_	_	_	_	B-Manner
10	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Manner
11	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Manner
12	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Manner
13	bonds	_	bond	_	NNS	8	_	_	_	_	_	_	_	I-Manner
14	,	_	,	_	,	8	_	_	_	_	_	_	_	I-Manner
15	amide	_	UNK	_	RB	8	_	_	_	_	_	_	_	I-Manner
16	linkage	_	UNK	_	NN	8	_	_	_	_	_	_	_	I-Manner
17	,	_	,	_	,	8	_	_	_	_	_	_	_	I-Manner
18	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Manner
19	bonds	_	bond	_	NNS	8	_	_	_	_	_	_	_	I-Manner
20	,	_	,	_	,	8	_	_	_	_	_	_	_	I-Manner
21	and	_	and	_	CC	8	_	_	_	_	_	_	_	I-Manner
22	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Manner
23	bonds	_	bond	_	NNS	8	_	_	_	_	_	_	_	I-Manner
24	are	_	be	_	VBP	8	_	_	_	_	_	_	_	I-Manner
25	also	_	also	_	RB	8	_	_	_	_	_	_	_	I-Manner
26	thoroughly	_	UNK	_	RB	8	_	_	_	_	_	_	_	I-Manner
27	described	_	describe	_	VBN	8	_	_	_	_	_	_	_	I-Manner
28	.	_	.	_	.	8	_	_	_	_	_	_	_	I-Manner

1	principles	_	UNK	_	NNS	8	_	_	_	_	_	_	_	B-Participants
2	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Participants
3	covalent	_	UNK	_	JJ	8	_	_	_	_	_	_	_	I-Participants
4	conjugation	_	conjugation	_	NN	8	_	_	_	_	_	_	_	I-Participants
5	of	_	of	_	IN	8	_	_	_	_	_	_	_	I-Participants
6	drugs	_	drug	_	NNS	8	_	_	_	_	_	_	_	I-Participants
7	with	_	with	_	IN	8	_	_	_	_	_	with.prep	Accompaniment	O
8	unk	_	UNK	_	NNP	8	_	_	_	_	_	_	_	S-Co-participant
9	including	_	include	_	VBG	8	_	_	_	_	_	_	_	O
10	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
12	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
13	bonds	_	bond	_	NNS	8	_	_	_	_	_	_	_	O
14	,	_	,	_	,	8	_	_	_	_	_	_	_	O
15	amide	_	UNK	_	RB	8	_	_	_	_	_	_	_	O
16	linkage	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
17	,	_	,	_	,	8	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
19	bonds	_	bond	_	NNS	8	_	_	_	_	_	_	_	O
20	,	_	,	_	,	8	_	_	_	_	_	_	_	O
21	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
23	bonds	_	bond	_	NNS	8	_	_	_	_	_	_	_	O
24	are	_	be	_	VBP	8	_	_	_	_	_	_	_	O
25	also	_	also	_	RB	8	_	_	_	_	_	_	_	O
26	thoroughly	_	UNK	_	RB	8	_	_	_	_	_	_	_	O
27	described	_	describe	_	VBN	8	_	_	_	_	_	_	_	O
28	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	finally	_	Finally	_	RB	9	_	_	_	_	_	finally.adv	Time_vector	O
2	,	_	,	_	,	9	_	_	_	_	_	_	_	O
3	results	_	result	_	NNS	9	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	9	_	_	_	_	_	_	_	O
5	clinical	_	UNK	_	JJ	9	_	_	_	_	_	_	_	O
6	trials	_	trial	_	NNS	9	_	_	_	_	_	_	_	O
7	obtained	_	obtain	_	VBN	9	_	_	_	_	_	_	_	O
8	with	_	with	_	IN	9	_	_	_	_	_	_	_	O
9	polymeric	_	polymeric	_	JJ	9	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
11	magnetic	_	magnetic	_	JJ	9	_	_	_	_	_	_	_	O
12	carriers	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
13	are	_	be	_	VBP	9	_	_	_	_	_	_	_	O
14	analyzed	_	UNK	_	VBN	9	_	_	_	_	_	_	_	O
15	highlighting	_	highlight	_	VBG	9	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	9	_	_	_	_	_	_	_	O
17	potential	_	potential	_	JJ	9	_	_	_	_	_	_	_	O
18	advantages	_	advantage	_	NNS	9	_	_	_	_	_	_	_	O
19	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
20	future	_	future	_	JJ	9	_	_	_	_	_	_	_	O
21	directions	_	direction	_	NNS	9	_	_	_	_	_	_	_	O
22	in	_	in	_	IN	9	_	_	_	_	_	_	_	O
23	targeted	_	targeted	_	JJ	9	_	_	_	_	_	_	_	O
24	anticancer	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
25	therapy	_	therapy	_	NN	9	_	_	_	_	_	_	_	O
26	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	finally	_	Finally	_	RB	9	_	_	_	_	_	_	_	S-Goods
2	,	_	,	_	,	9	_	_	_	_	_	_	_	B-Unit
3	results	_	result	_	NNS	9	_	_	_	_	_	result.n	Earnings_and_losses	I-Unit
4	of	_	of	_	IN	9	_	_	_	_	_	_	_	I-Unit
5	clinical	_	UNK	_	JJ	9	_	_	_	_	_	_	_	I-Unit
6	trials	_	trial	_	NNS	9	_	_	_	_	_	_	_	I-Unit
7	obtained	_	obtain	_	VBN	9	_	_	_	_	_	_	_	I-Unit
8	with	_	with	_	IN	9	_	_	_	_	_	_	_	I-Unit
9	polymeric	_	polymeric	_	JJ	9	_	_	_	_	_	_	_	I-Unit
10	and	_	and	_	CC	9	_	_	_	_	_	_	_	I-Unit
11	magnetic	_	magnetic	_	JJ	9	_	_	_	_	_	_	_	I-Unit
12	carriers	_	UNK	_	NNS	9	_	_	_	_	_	_	_	I-Unit
13	are	_	be	_	VBP	9	_	_	_	_	_	_	_	I-Unit
14	analyzed	_	UNK	_	VBN	9	_	_	_	_	_	_	_	I-Unit
15	highlighting	_	highlight	_	VBG	9	_	_	_	_	_	_	_	I-Unit
16	the	_	the	_	DT	9	_	_	_	_	_	_	_	I-Unit
17	potential	_	potential	_	JJ	9	_	_	_	_	_	_	_	I-Unit
18	advantages	_	advantage	_	NNS	9	_	_	_	_	_	_	_	I-Unit
19	and	_	and	_	CC	9	_	_	_	_	_	_	_	I-Unit
20	future	_	future	_	JJ	9	_	_	_	_	_	_	_	I-Unit
21	directions	_	direction	_	NNS	9	_	_	_	_	_	_	_	I-Unit
22	in	_	in	_	IN	9	_	_	_	_	_	_	_	I-Unit
23	targeted	_	targeted	_	JJ	9	_	_	_	_	_	_	_	I-Unit
24	anticancer	_	UNK	_	NN	9	_	_	_	_	_	_	_	I-Unit
25	therapy	_	therapy	_	NN	9	_	_	_	_	_	_	_	I-Unit
26	.	_	.	_	.	9	_	_	_	_	_	_	_	I-Unit

1	finally	_	Finally	_	RB	9	_	_	_	_	_	_	_	O
2	,	_	,	_	,	9	_	_	_	_	_	_	_	O
3	results	_	result	_	NNS	9	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	9	_	_	_	_	_	of.prep	Age	S-Degree
5	clinical	_	UNK	_	JJ	9	_	_	_	_	_	_	_	B-Age
6	trials	_	trial	_	NNS	9	_	_	_	_	_	_	_	I-Age
7	obtained	_	obtain	_	VBN	9	_	_	_	_	_	_	_	I-Age
8	with	_	with	_	IN	9	_	_	_	_	_	_	_	I-Age
9	polymeric	_	polymeric	_	JJ	9	_	_	_	_	_	_	_	I-Age
10	and	_	and	_	CC	9	_	_	_	_	_	_	_	I-Age
11	magnetic	_	magnetic	_	JJ	9	_	_	_	_	_	_	_	I-Age
12	carriers	_	UNK	_	NNS	9	_	_	_	_	_	_	_	I-Age
13	are	_	be	_	VBP	9	_	_	_	_	_	_	_	I-Age
14	analyzed	_	UNK	_	VBN	9	_	_	_	_	_	_	_	I-Age
15	highlighting	_	highlight	_	VBG	9	_	_	_	_	_	_	_	I-Age
16	the	_	the	_	DT	9	_	_	_	_	_	_	_	I-Age
17	potential	_	potential	_	JJ	9	_	_	_	_	_	_	_	I-Age
18	advantages	_	advantage	_	NNS	9	_	_	_	_	_	_	_	I-Age
19	and	_	and	_	CC	9	_	_	_	_	_	_	_	I-Age
20	future	_	future	_	JJ	9	_	_	_	_	_	_	_	I-Age
21	directions	_	direction	_	NNS	9	_	_	_	_	_	_	_	I-Age
22	in	_	in	_	IN	9	_	_	_	_	_	_	_	I-Age
23	targeted	_	targeted	_	JJ	9	_	_	_	_	_	_	_	I-Age
24	anticancer	_	UNK	_	NN	9	_	_	_	_	_	_	_	I-Age
25	therapy	_	therapy	_	NN	9	_	_	_	_	_	_	_	O
26	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	finally	_	Finally	_	RB	9	_	_	_	_	_	_	_	B-Tester
2	,	_	,	_	,	9	_	_	_	_	_	_	_	I-Tester
3	results	_	result	_	NNS	9	_	_	_	_	_	_	_	I-Tester
4	of	_	of	_	IN	9	_	_	_	_	_	_	_	I-Tester
5	clinical	_	UNK	_	JJ	9	_	_	_	_	_	_	_	S-Purpose
6	trials	_	trial	_	NNS	9	_	_	_	_	_	trial.n	Operational_testing	S-Degree
7	obtained	_	obtain	_	VBN	9	_	_	_	_	_	_	_	B-Manner
8	with	_	with	_	IN	9	_	_	_	_	_	_	_	I-Manner
9	polymeric	_	polymeric	_	JJ	9	_	_	_	_	_	_	_	I-Manner
10	and	_	and	_	CC	9	_	_	_	_	_	_	_	I-Manner
11	magnetic	_	magnetic	_	JJ	9	_	_	_	_	_	_	_	I-Manner
12	carriers	_	UNK	_	NNS	9	_	_	_	_	_	_	_	I-Manner
13	are	_	be	_	VBP	9	_	_	_	_	_	_	_	I-Manner
14	analyzed	_	UNK	_	VBN	9	_	_	_	_	_	_	_	I-Manner
15	highlighting	_	highlight	_	VBG	9	_	_	_	_	_	_	_	I-Manner
16	the	_	the	_	DT	9	_	_	_	_	_	_	_	I-Manner
17	potential	_	potential	_	JJ	9	_	_	_	_	_	_	_	I-Manner
18	advantages	_	advantage	_	NNS	9	_	_	_	_	_	_	_	I-Manner
19	and	_	and	_	CC	9	_	_	_	_	_	_	_	I-Manner
20	future	_	future	_	JJ	9	_	_	_	_	_	_	_	I-Manner
21	directions	_	direction	_	NNS	9	_	_	_	_	_	_	_	I-Manner
22	in	_	in	_	IN	9	_	_	_	_	_	_	_	I-Manner
23	targeted	_	targeted	_	JJ	9	_	_	_	_	_	_	_	I-Manner
24	anticancer	_	UNK	_	NN	9	_	_	_	_	_	_	_	I-Manner
25	therapy	_	therapy	_	NN	9	_	_	_	_	_	_	_	I-Manner
26	.	_	.	_	.	9	_	_	_	_	_	_	_	I-Manner

1	finally	_	Finally	_	RB	9	_	_	_	_	_	_	_	B-Degree
2	,	_	,	_	,	9	_	_	_	_	_	_	_	I-Degree
3	results	_	result	_	NNS	9	_	_	_	_	_	_	_	I-Degree
4	of	_	of	_	IN	9	_	_	_	_	_	_	_	I-Degree
5	clinical	_	UNK	_	JJ	9	_	_	_	_	_	_	_	I-Degree
6	trials	_	trial	_	NNS	9	_	_	_	_	_	_	_	I-Degree
7	obtained	_	obtain	_	VBN	9	_	_	_	_	_	_	_	I-Degree
8	with	_	with	_	IN	9	_	_	_	_	_	_	_	I-Degree
9	polymeric	_	polymeric	_	JJ	9	_	_	_	_	_	_	_	I-Degree
10	and	_	and	_	CC	9	_	_	_	_	_	_	_	I-Degree
11	magnetic	_	magnetic	_	JJ	9	_	_	_	_	_	_	_	I-Degree
12	carriers	_	UNK	_	NNS	9	_	_	_	_	_	_	_	I-Degree
13	are	_	be	_	VBP	9	_	_	_	_	_	_	_	I-Degree
14	analyzed	_	UNK	_	VBN	9	_	_	_	_	_	_	_	I-Degree
15	highlighting	_	highlight	_	VBG	9	_	_	_	_	_	_	_	I-Degree
16	the	_	the	_	DT	9	_	_	_	_	_	_	_	S-Time
17	potential	_	potential	_	JJ	9	_	_	_	_	_	potential.a	Capability	S-Degree
18	advantages	_	advantage	_	NNS	9	_	_	_	_	_	_	_	B-Event
19	and	_	and	_	CC	9	_	_	_	_	_	_	_	I-Event
20	future	_	future	_	JJ	9	_	_	_	_	_	_	_	I-Event
21	directions	_	direction	_	NNS	9	_	_	_	_	_	_	_	I-Event
22	in	_	in	_	IN	9	_	_	_	_	_	_	_	I-Event
23	targeted	_	targeted	_	JJ	9	_	_	_	_	_	_	_	B-Degree
24	anticancer	_	UNK	_	NN	9	_	_	_	_	_	_	_	I-Degree
25	therapy	_	therapy	_	NN	9	_	_	_	_	_	_	_	I-Degree
26	.	_	.	_	.	9	_	_	_	_	_	_	_	I-Degree

1	finally	_	Finally	_	RB	9	_	_	_	_	_	_	_	B-Landmark_event
2	,	_	,	_	,	9	_	_	_	_	_	_	_	I-Landmark_event
3	results	_	result	_	NNS	9	_	_	_	_	_	_	_	I-Landmark_event
4	of	_	of	_	IN	9	_	_	_	_	_	_	_	I-Landmark_event
5	clinical	_	UNK	_	JJ	9	_	_	_	_	_	_	_	I-Landmark_event
6	trials	_	trial	_	NNS	9	_	_	_	_	_	_	_	I-Landmark_event
7	obtained	_	obtain	_	VBN	9	_	_	_	_	_	_	_	I-Landmark_event
8	with	_	with	_	IN	9	_	_	_	_	_	_	_	I-Landmark_event
9	polymeric	_	polymeric	_	JJ	9	_	_	_	_	_	_	_	I-Landmark_event
10	and	_	and	_	CC	9	_	_	_	_	_	_	_	I-Landmark_event
11	magnetic	_	magnetic	_	JJ	9	_	_	_	_	_	_	_	I-Landmark_event
12	carriers	_	UNK	_	NNS	9	_	_	_	_	_	_	_	I-Landmark_event
13	are	_	be	_	VBP	9	_	_	_	_	_	_	_	I-Landmark_event
14	analyzed	_	UNK	_	VBN	9	_	_	_	_	_	_	_	I-Landmark_event
15	highlighting	_	highlight	_	VBG	9	_	_	_	_	_	_	_	I-Landmark_event
16	the	_	the	_	DT	9	_	_	_	_	_	_	_	I-Landmark_event
17	potential	_	potential	_	JJ	9	_	_	_	_	_	_	_	I-Landmark_event
18	advantages	_	advantage	_	NNS	9	_	_	_	_	_	_	_	I-Landmark_event
19	and	_	and	_	CC	9	_	_	_	_	_	_	_	S-Trajector_event
20	future	_	future	_	JJ	9	_	_	_	_	_	future.a	Temporal_collocation	S-Trajector_entity
21	directions	_	direction	_	NNS	9	_	_	_	_	_	_	_	B-Trajector_event
22	in	_	in	_	IN	9	_	_	_	_	_	_	_	I-Trajector_event
23	targeted	_	targeted	_	JJ	9	_	_	_	_	_	_	_	B-Trajector_period
24	anticancer	_	UNK	_	NN	9	_	_	_	_	_	_	_	I-Trajector_period
25	therapy	_	therapy	_	NN	9	_	_	_	_	_	_	_	I-Trajector_period
26	.	_	.	_	.	9	_	_	_	_	_	_	_	I-Trajector_period

1	finally	_	Finally	_	RB	9	_	_	_	_	_	_	_	B-Degree
2	,	_	,	_	,	9	_	_	_	_	_	_	_	I-Degree
3	results	_	result	_	NNS	9	_	_	_	_	_	_	_	I-Degree
4	of	_	of	_	IN	9	_	_	_	_	_	_	_	I-Degree
5	clinical	_	UNK	_	JJ	9	_	_	_	_	_	_	_	I-Degree
6	trials	_	trial	_	NNS	9	_	_	_	_	_	_	_	I-Degree
7	obtained	_	obtain	_	VBN	9	_	_	_	_	_	_	_	I-Degree
8	with	_	with	_	IN	9	_	_	_	_	_	_	_	I-Degree
9	polymeric	_	polymeric	_	JJ	9	_	_	_	_	_	_	_	I-Degree
10	and	_	and	_	CC	9	_	_	_	_	_	_	_	I-Degree
11	magnetic	_	magnetic	_	JJ	9	_	_	_	_	_	_	_	I-Degree
12	carriers	_	UNK	_	NNS	9	_	_	_	_	_	_	_	I-Degree
13	are	_	be	_	VBP	9	_	_	_	_	_	_	_	I-Degree
14	analyzed	_	UNK	_	VBN	9	_	_	_	_	_	_	_	I-Degree
15	highlighting	_	highlight	_	VBG	9	_	_	_	_	_	_	_	I-Degree
16	the	_	the	_	DT	9	_	_	_	_	_	_	_	I-Degree
17	potential	_	potential	_	JJ	9	_	_	_	_	_	_	_	I-Degree
18	advantages	_	advantage	_	NNS	9	_	_	_	_	_	_	_	I-Degree
19	and	_	and	_	CC	9	_	_	_	_	_	_	_	I-Degree
20	future	_	future	_	JJ	9	_	_	_	_	_	_	_	I-Degree
21	directions	_	direction	_	NNS	9	_	_	_	_	_	_	_	O
22	in	_	in	_	IN	9	_	_	_	_	_	_	_	O
23	targeted	_	targeted	_	JJ	9	_	_	_	_	_	_	_	O
24	anticancer	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
25	therapy	_	therapy	_	NN	9	_	_	_	_	_	therapy.n	Cure	S-Degree
26	.	_	.	_	.	9	_	_	_	_	_	_	_	S-Manner

